The Maryland government’s psychedelics task force has released a final report to state lawmakers, recommending a phased implementation of a wide range of reforms to provide legal therapeutic access to substances such as psilocybin while eventually creating a regulatory pathway for broader commercial sales.
About four months after issuing an interim report, the Maryland Task Force on Responsible Use of Natural Psychedelic Substances advised that it’s ultimately recommending a “multi-pathway framework for safe, broad, and equitable access to natural psychedelic substances, with an initial focus on psilocybin.”
The psychedelics task force was formed following Gov. Wes Moore’s (D) signing of a pair of bills into law in May of last year. The 17-person body, overseen by the Maryland Cannabis Administration (MCA), is charged with studying how to ensure “broad, equitable and affordable access to psychedelic substances” in the state.
“This report represents an unprecedented collaborative effort drawing on Maryland’s legacy and leadership in psychedelic science,” Andrew Coop, chair of the task force and a professor at the University of Maryland School of Pharmacy, said in a press release. “Our goal has been to provide evidence-based recommendations that prioritize public health, patient safety, equity, and scientific integrity.”
The multi-step regulatory framework
Read full article on Marijuana Moment
